HomepageBlogMitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market Blog Market Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market admin Posted on August 14, 2023 Mitsui Chemicals Inc. (TYO:4183) plans to get back involved in the CDMO business for nucleic acid drugs. By 2025, the…… Please subscribe to read the full story. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Post navigation Next PostChemical Innovation: Unveiling the Dynamics of Japan’s Thriving Chemical Industry You Might Also Like Blog Ube Industries Moves to Increase Polyamide Elastomer Production admin August 14, 2023 Blog Cefic Highlights Urgent Action Needed to Diversify Procurement admin August 14, 2023 Blog Zeon Targets 50% Cut to CO2 Emissions by 2030 admin August 14, 2023 Blog China Raises NEV Target, Signaling Growing Opportunities in Battery Materials admin August 14, 2023
Blog China Raises NEV Target, Signaling Growing Opportunities in Battery Materials admin August 14, 2023